Foghorn Therapeutics

Foghorn Therapeutics discovers and develops novel drugs to treat cancer and other serious medical disorders. The company seeks to discover novel therapeutics that target chromatin remodeling complexes. Foghorn uses a proprietary platform based on revolutionary advances in mechanistic understanding of disease.


Company Profile

Foghorn Therapeutics Logo
  • Founded: 2016

Flagship Partners:

  • Doug Cole, Managing Partner